Teva Pharmaceutical Industries Limited · TASE:TEVA
Lippman Evan sold 18,600 Teva Pharmaceutical Industries Limited shares (Form 4)
Traded Aug 17, 2026 · Filed Aug 19, 2026
On Aug 17, 2026, Lippman Evan (EVP, Business Development) sold 18,600 Teva Pharmaceutical Industries Limited shares at US$36.57 for US$680K under a trading plan, leaving 25,591 shares. Filed Aug 19, 2026 (Form 4).
- Sold
- 18,600 shares
- Price
- US$36.57
- Value
- US$680K
- Holding after
- 25,591 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Business Development
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Ordinary Shares | Sale | 18,600 | US$36.57 | 25,591 | Direct |
Source
Related
- Teva Pharmaceutical Industries Limited
- Lippman Evan
- Teva Pharmaceutical Industries Limited shareholders
- Form 4 · Lippman Evan · May 18, 2026
- Form 4 · Savage Brian · Sep 22, 2026
- Form 4 · Mignone Roberto · Sep 22, 2026
- Form 4 · Weiss Amir · Aug 25, 2026
- Form 4 · Satchi-Fainaro Ronit · Aug 25, 2026
- Form 4 · Zaks Tal Zvi · Aug 10, 2026